Benzafibrate Dispersible Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20070265
Indications:
For the treatment of: Hypertriglyceridemia, Hypercholesterolemia, Mixed hyperlipidemia.
Administration:
Dosage for Adults:
Standard regimen: 0.2-0.4g three times daily, to be taken after meals or with food. Maintenance dose (for optimal responders): 0.4g twice daily.
Renal Impairment Adjustment (by creatinine clearance rate):
40-60 mL/min: 0.4g twice daily
15-40 mL/min: 0.4g once daily or every other day
<15 mL/min: 0.4g every 3 days
Specifications:
10mg x 7 tablets, 10mg x 10 tabl
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.